Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.29 and traded as high as $2.70. Organicell Regenerative Medicine shares last traded at $2.6380, with a volume of 2,787 shares.
Organicell Regenerative Medicine Price Performance
The stock’s 50-day moving average is $2.29 and its 200 day moving average is $1.92.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Featured Stories
- Five stocks we like better than Organicell Regenerative Medicine
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
